FIGURE
Fig. 2
- ID
- ZDB-FIG-110405-12
- Publication
- Choi et al., 2011 - Aplexone targets the HMG-CoA reductase pathway and differentially regulates arteriovenous angiogenesis
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 2
Aplexone does not affect arterial and venous fate. Untreated control embryos (A,A′,C,C′,E,E′) and embryos treated with 10 μM aplexone beginning at 10 hpf (B,B′,D,D′,F,F′) were fixed at 24 hpf. (A-F′) Arterial and venous fates were analyzed by in situ hybridization using ephrinB2a (A,A′,B,B′), ephB4 (C,C′,D,D′) and flt4 (E,E′,F,F′) probes. Arrowheads indicate the dorsal aorta. Embryos were analyzed at higher magnification in the trunk in A′-F′, with regions of interest indicated by black boxes in A-F. Arrows indicate the posterior cardinal vein. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Development